Valuation: McKesson Corporation

Market Cap 100B 86.55B 81.2B 73.96B 139B 9,586B 141B 952B 373B 4,803B 376B 368B 15,976B P/E 2027 *
22x
P/E 2028 * 17.5x
Enterprise Value 104B 90.03B 84.46B 76.93B 145B 9,971B 147B 990B 388B 4,995B 392B 383B 16,617B EV / Sales 2027 *
0.24x
EV / Sales 2028 * 0.22x
Free-Float
41.53%
Yield 2027 *
0.42%
Yield 2028 * 0.44%
1 day+0.71%
1 week-2.00%
Current month+2.33%
1 month+2.55%
1 week 699.94
Extreme 699.9445
724.62
1 month 669.8
Extreme 669.8045
742.63
Current year 603.78
Extreme 603.777
742.63
1 year 603.78
Extreme 603.777
742.63
3 years 603.78
Extreme 603.777
742.63
5 years 603.78
Extreme 603.777
742.63
10 years 603.78
Extreme 603.777
742.63
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2019
Chief Tech/Sci/R&D Officer 53 03/10/2023
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 70 24/04/2018
Chairman 59 01/05/2026
Director/Board Member 68 12/09/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.71%-2.00% - - 100B
-1.04%-2.27%+27.76%+106.24% 100B
+0.21%-0.64%+57.52%+172.79% 54.81B
-1.53%-2.19%+1.57%+279.74% 24.13B
-0.72%-1.50%-12.44%-15.93% 8.19B
-0.94%-0.64%-31.55%-23.57% 7.66B
+0.60%+0.42%-12.71%-20.28% 6.68B
+1.46%+3.75%+10.45%+18.78% 6.42B
-0.18%-1.52%-3.17%+15.56% 4.98B
-1.38%-1.19%-6.55%-9.06% 3.69B
Average -0.28%-0.85%+3.43%+58.25% 24.09B
Weighted average by Cap. -0.20%-1.34%+25.70%+122.64%

Financials

2027 *2028 *
Net sales 432B 373B 350B 319B 599B 41,298B 607B 4,101B 1,607B 20,690B 1,622B 1,586B 68,824B 463B 399B 375B 341B 642B 44,221B 650B 4,391B 1,721B 22,155B 1,736B 1,699B 73,697B
Net income 4.69B 4.05B 3.8B 3.46B 6.51B 448B 6.6B 44.53B 17.45B 225B 17.61B 17.23B 747B 5.62B 4.85B 4.55B 4.15B 7.8B 537B 7.9B 53.36B 20.91B 269B 21.1B 20.64B 896B
Net Debt 4.03B 3.48B 3.26B 2.97B 5.58B 385B 5.66B 38.22B 14.98B 193B 15.11B 14.79B 641B 2.72B 2.35B 2.2B 2.01B 3.77B 260B 3.83B 25.83B 10.12B 130B 10.22B 9.99B 434B
Logo McKesson Corporation
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.
Employees
42,300
Date Price Change
17/08/26 CHF 706.64 +0.71%
14/08/26 CHF 701.68 +0.25%
13/08/26 CHF 699.94 -3.41%
12/08/26 CHF 724.62 -0.09%
11/08/26 CHF 725.30 +0.59%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
859.92USD
Average target price
991.40USD
Spread / Average Target
+15.29%

Quarterly revenue - Rate of surprise